Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto K, Nakayamada S, Fujino Y, Miyata H, Kubo S, Fujita Y, Inoue Y, Matsunaga S, Iwata S, Hanami K, Todoroki Y, Yoshinari-Korekoda H, Kawabe A, Yamaguchi A, Ueno M, Satoh-Kanda Y, Kanda R, Funada M, Ohkubo N, Kusaka K, Kosaka S, Nagayasu A, Fukuyo S, Nawata M, Miyazaki Y, Tokunaga M, Tanaka K, Okada Y, Tanaka Y. Sonomoto K, et al. Among authors: kanda r. Rheumatology (Oxford). 2023 Nov 2:kead579. doi: 10.1093/rheumatology/kead579. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37934120
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo S, Miyazaki Y, Todoroki Y, Nagayasu A, Kanda R, Aritomi T, Matsunaga S, Ueno M, Miyagawa I, Sonomoto K, Hanami K, Nakayamada S, Tanaka Y. Kubo S, et al. Among authors: kanda r. Rheumatol Ther. 2023 Dec;10(6):1705-1723. doi: 10.1007/s40744-023-00603-8. Epub 2023 Oct 19. Rheumatol Ther. 2023. PMID: 37856034 Free PMC article.
Identification of compounds that preferentially suppress the growth of T-cell acute lymphoblastic leukemia-derived cells.
Miyashita K, Yagi T, Kagaya N, Takechi A, Nakata C, Kanda R, Nuriya H, Tanegashima K, Hoyano S, Seki F, Yoshida C, Hachiro Y, Higashi T, Kitada N, Toya T, Kobayashi T, Najima Y, Goyama S, Maki SA, Kitamura T, Doki N, Shin-Ya K, Hara T. Miyashita K, et al. Among authors: kanda r. Cancer Sci. 2023 Oct;114(10):4032-4040. doi: 10.1111/cas.15918. Epub 2023 Jul 31. Cancer Sci. 2023. PMID: 37522388 Free PMC article.
Barriers to patient recruitment in a poststroke neurorehabilitation multicenter trial in Brazil.
Silva TRD, Luvizutto GJ, Martins LG, Costa RDMD, Souza JT, Winckler FC, Sartor LCA, Modolo GP, Ferreira NC, Rodrigues JCS, Kanda RG, Fogaroli MO, Borges GF, Rizzatti GRS, Ribeiro PW, Pires DS, Favoretto DB, Aguiar LR, Bazan SGZ, Betting LEG, Antunes LCO, Nunes HRC, Pereira VM, Edwards TGS, Pontes-Neto O, Conforto AB, Bazan R. Silva TRD, et al. Among authors: kanda rg. Braz J Med Biol Res. 2023 Jan 27;56:e12326. doi: 10.1590/1414-431X2023e12326. eCollection 2023. Braz J Med Biol Res. 2023. PMID: 36722659 Free PMC article. Clinical Trial.
TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus.
Shan Y, Nakayamada S, Nawata A, Yamagata K, Sonomoto K, Tanaka H, Satoh-Kanda Y, Nguyen MP, Todoroki Y, Nagayasu A, Ueno M, Kanda R, Fujita Y, Zhang T, Hao H, Zhou J, Ma X, Anan J, Nguyen AP, Tanaka Y. Shan Y, et al. Among authors: kanda r. Rheumatology (Oxford). 2023 Jul 5;62(7):2464-2474. doi: 10.1093/rheumatology/keac646. Rheumatology (Oxford). 2023. PMID: 36370078
159 results